Wearable Injector Market by Type, Technology, Application, End-Use, Distribution Channel

List of Tables

[198 Pages Report] The Wearable Injector Market size was estimated at USD 7.84 billion in 2023 and expected to reach USD 8.71 billion in 2024, at a CAGR 11.26% to reach USD 16.56 billion by 2030.

Wearable injectors are innovative medical devices designed to deliver large volumes of drugs subcutaneously to patients in a convenient, safe, and less painful way compared to traditional syringe-based injections. These devices adhere to the patient's body, allowing for mobility and flexibility while administering viscous, high-volume drugs over a predefined time period. Wearable injectors have emerged as a breakthrough in the administration of drugs for chronic diseases such as diabetes, cancer, cardiovascular diseases, and autoimmune disorders. The adoption of wearable injectors is primarily propelled by the rising prevalence of chronic diseases that require continuous medication, such as diabetes and autoimmune diseases. The convenience and efficiency of wearable injectors, coupled with patient preference for self-administration, support the wearable injectors market expansion. Despite the progressive momentum, the wearable injectors market faces several challenges owing to the high cost associated with the development and manufacturing of these devices and the requirement for regulatory compliance and approval across different regions, which can prolong market entry for new devices. However, increasing demand for biologics, which often require precise dosing and slow release mechanisms provided by wearable injectors, opens new avenues for growth. The trend towards telehealth and remote patient monitoring creates demand for advanced wearable injectors with connectivity features.

KEY MARKET STATISTICS
Base Year [2023]	USD 7.84 billion
Estimated Year [2024]	USD 8.71 billion
Forecast Year [2030]	USD 16.56 billion
CAGR (%)	11.26%

Regional Insights

The wearable injectors market in the Americas is characterized by advanced healthcare infrastructure and high healthcare expenditure. The increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases, coupled with a high demand for biologics, drives the adoption of wearable injectors in the region. Regulatory support for medical devices also plays a vital role in the rapid approval and commercialization of wearable injectors. Europe, with its robust healthcare systems, increased healthcare spending, and high awareness regarding advanced therapeutic devices, demonstrates higher adoption of wearable injectors. The market in the Middle East and Africa, however, is gradually growing, fueled by improving healthcare infrastructure, increasing government initiatives, and rising chronic disease prevalence. The APAC region is anticipated to witness the fastest growth in the wearable injectors market owing to its rapidly improving healthcare infrastructure, increasing disposable income, and growing awareness of advanced treatment methods. China, Japan, and South Korea are at the forefront of the adoption of wearable injectors, driven by technological advancements and supportive government policies. The region's vast population base, coupled with an increasing prevalence of chronic conditions, presents a significant opportunity for market expansion.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Wearable Injector Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Growing prevalence of chronic diseases and high need for advanced drug delivery device
- Rising preferences for minimally invasive treatments

Market Restraints
- High costs associated with wearable injector development

Market Opportunities
- Technological advancements in wearable injector technology
- Growing significance of telehealth solutions

Market Challenges
- Challenges associated with strigent approval and regulatory compliances

Market Segmentation Analysis
- Types: Rising adoption for compact body worn patch injector
- End-Use: Growing significance of wearable injectors in telehealth applications in home care settings

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Wearable Injector Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Wearable Injector Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

FDA Approves Enable Injections' Wearable Injector

Enable Injections has announced the FDA approval of its Empaveli Injector, a wearable device revolutionizing the administration of subcutaneous therapy. Designed specifically for adults with paroxysmal nocturnal hemoglobinuria, the Empaveli Injector simplifies the treatment process by enabling hands-free delivery of up to 25 mL of medication, suitable for both home and clinical settings. With this advancement, Enable Injections aims to enhance patient care and also extend its reach through additional enFuse partnerships, ultimately elevating patient support on a global scale. [Published On: 2023-10-02]

Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections

Viridian Therapeutics, Inc., a biotechnology entity dedicated to crafting leading-edge treatments for grave and rare conditions, has collaborated with Enable Injections. This union aims to employ Enable's enFuse wearable drug delivery system, capable of administering up to 25mL, to improve patient care. This collaboration focuses on enhancing drug delivery convenience outside the scope of Viridian's Thyroid Eye Disease (TED) ventures, showing a deep commitment to patient-centered innovation. [Published On: 2023-05-08]

LTS Acquires Sorrel Wearable Injection Device Business

LTS Lohmann, a pharmaceutical technology company, has acquired the Sorrel wearable injector business from Eitan Medical Ltd., based in Netanya, Israel. This acquisition marks a significant leap for LTS, expanding its range of drug delivery solutions to include Sorrel's advanced large-volume wearable injector technologies, which are pivotal for the administration of large molecules and biologics. [Published On: 2023-04-21]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Wearable Injector Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Wearable Injector Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Becton, Dickinson and Company, CCBio, CeQur Corporation, DCA Design International Ltd, Debiotech SA, E3D Elcam Drug Delivery Devices, Enable Injections, Inc., EOFlow Co., Ltd., Gerresheimer AG, Insulet Corporation, LTS Lohmann Therapie-Systeme AG, Medtrum Technologies Inc., Neuma LLC by Kymanox Corporation, Noble International LLC by AptarGroup, Inc., NOVO Engineering, Shaily Engineering Plastics Ltd., SONCEBOZ SA, Stevanato Group S.p.A., Subcuject ApS, Viant, West Pharmaceutical Services, Inc., Ypsomed Holding AG, and ZwickRoell GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Wearable Injector Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Body Worn Patch Injector
- Off Body Worn Patch Injector

Technology
- Expanding Battery
- Motor Driven
- Rotary Pump
- Spring-based

Application
- Autoimmune Disease
- Cardiovascular Disease
- Diabetes
- Infectious Disease
- Oncology

End-Use
- Home Care Setting
- Hospitals & Clinics

Distribution Channel
- Offline
- Online

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-031AB52F47BF

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing prevalence of chronic diseases and high need for advanced drug delivery device
  - 5.1.1.2. Rising preferences for minimally invasive treatments
- 5.1.2. Restraints
  - 5.1.2.1. High costs associated with wearable injector development
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in wearable injector technology
  - 5.1.3.2. Growing significance of telehealth solutions
- 5.1.4. Challenges
  - 5.1.4.1. Challenges associated with strigent approval and regulatory compliances
5.2. Market Segmentation Analysis
- 5.2.1. Types: Rising adoption for compact body worn patch injector
- 5.2.2. End-Use: Growing significance of wearable injectors in telehealth applications in home care settings
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Wearable Injector Market, by Type

6.1. Introduction
6.2. Body Worn Patch Injector
6.3. Off Body Worn Patch Injector

7. Wearable Injector Market, by Technology

7.1. Introduction
7.2. Expanding Battery
7.3. Motor Driven
7.4. Rotary Pump
7.5. Spring-based

8. Wearable Injector Market, by Application

8.1. Introduction
8.2. Autoimmune Disease
8.3. Cardiovascular Disease
8.4. Diabetes
8.5. Infectious Disease
8.6. Oncology

9. Wearable Injector Market, by End-Use

9.1. Introduction
9.2. Home Care Setting
9.3. Hospitals & Clinics

10. Wearable Injector Market, by Distribution Channel

10.1. Introduction
10.2. Offline
10.3. Online

11. Americas Wearable Injector Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Wearable Injector Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Wearable Injector Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. FDA Approves Enable Injections' Wearable Injector
- 14.3.2. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
- 14.3.3. LTS Acquires Sorrel Wearable Injection Device Business
14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio